Second Affiliated Hospital, School of Medicine, Zhejiang University — Hangzhou, Zhejiang / 浙江

Public research footprint of Second Affiliated Hospital, School of Medicine, Zhejiang University, compiled from the ClinicalTrials.gov public registry.

176

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Carcinoma, Non-Small-Cell Lung · Heart Failure · Cardiogenic Shock Post Myocardial Infarction

Recently updated registry entries

NCT05488314 — A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… (Active Not Recruiting)
NCT04988295 — A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy… (Active Not Recruiting)
NCT05584020 — Arthroscopic Anterior Cruciate Ligament Repair Versus Reconstruction for Acute Anterior… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Second Affiliated Hospital, School of Medicine, Zhejiang University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.